Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein ≥2 mg/L; p=0.003) and ischemic HFrEF etiology ...
Canada NewsWire MISSISSAUGA, ON, Nov. 27, 2024 MISSISSAUGA, ON, Nov. 27, 2024 /CNW/ - Novo Nordisk announced today that Wegovy® (semaglutide injection) is now approved to reduce ...